Skip to content
Home/Companies/HealthTech/Primo Group
Primo Group

Primo Group

HealthTech·Italy·Exited 2024·Held 9yr
Entry
2015
Hold
9yr
Exit
2024

Who owns Primo Group?

Primo Group is an Italian HealthTech company, now owned by Aksia, which acquired it in 2024 from ARCHIMED.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

HQItaly
SectorHealthTech
Websiteprimogroup.eu
Key takeaways
  • ·Fully exited in 2024 to Aksia.
  • ·Best return: 3.0x MOIC by ARCHIMED (2024 exit).
Exit Type
Secondary
Buyer
Aksia
MOIC
3.0x
Exit Year
2024

More from MED I

Other portfolio companies in the same fund.

Stago
Stago
Active
MedTechFrance· 2026
Fytexia
4.0xExited 2023
HealthTechFrance· 2016
to Associated British Foods
Micromed
Micromed
Exited 2023
MedTechFrance· 2016
to Natus Medical (ARCHIMED portfolio company, intra-portfolio)
Natural Origins
Natural Origins
2.5xExited 2017
HealthTechFrance· 2016
to Dohler Group
Polyplus
Polyplus
300.0xExited 2023
BiotechFrance· 2016
to Sartorius Stedim
Deallus
Exited 2024
PharmaUK· 2015
to GlobalData Plc

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Primo Group?

Primo Group is now owned by Aksia, which acquired it in 2024 from ARCHIMED.

When did Aksia acquire Primo Group?

Aksia acquired Primo Group in 2024, buying from ARCHIMED.

Who did Primo Group sell to?

ARCHIMED sold Primo Group to Aksia in 2024 (Secondary), 3.0x return.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue